Blueprint Medicines Corporation (LON:0HOJ)
London
· Delayed Price · Currency is GBP · Price in USD 84.70
+0.44 (0.52%)
At close: Apr 23, 2025
Blueprint Medicines Market Cap
Blueprint Medicines has a market cap or net worth of 4.13 billion as of April 24, 2025. Its market cap has decreased by -6.82% in one year.
Market Cap
4.13B
Enterprise Value
4.02B
Revenue
406.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
84.70
Market Cap Chart
Since April 30, 2015, Blueprint Medicines's market cap has increased from 317.21M to 4.13B, an increase of 1,201.54%. That is a compound annual growth rate of 29.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 157.23B |
| GSK plc | 55.19B |
| Haleon | 34.34B |
| Smith & Nephew | 8.58B |
| ConvaTec Group | 5.21B |
| Hikma Pharmaceuticals | 4.20B |
| HUTCHMED (China) | 1.98B |
| Oxford Nanopore Technologies | 1.13B |